In ring segments from rat basilar artery (BA) the endothelin (ET) peptides ET-l, ET-2, and ET-3 in duced concentration-related contractions. The order of potency was ET-l = ET-2> ET-3, while no differences occurred in the maximum contraction. The selective ETA receptor antagonist, BQ-123 (10-1 0 _10-4 M) alone elic ited a small contraction only at 10-4 M. In the presence of BQ-123 (10-7-10-5 M), the concentration-response curve for ET -1 was shifted to the right without any de crease in maximum contraction, indicating competitive inhibition of ET -1 binding to the ETA receptor by BQ-123. The pA2 value calculated for BQ-123 was 6. 935; the slope of the regression curve was 0.734. In contrast to ET -1, the contractile action of ET -3 was abolished by Endothelial cells play an important role in the regulation of vasomotor tone and thus of regional blood flow. Regulation is accomplished by releasing vasoactive compounds, which may induce relax ation as well as contraction of the underlying smooth muscle cells. Among the relaxant factors are prostacyclin (Moncada and Vane, 1979) and the "classical" endothelium-derived relaxing factor (EDRF) (Furchgott and Zawadzki, 1980) , which has been identified as nitric oxide or a nitric oxide containing moiety (Ignarro et aI., 1987; Palmer et aI., 1987). Among the contractile factors released from the endothelium are thromboxane A2 (Mon cada and Vane, 1979) and endothelin (ET), a 21-Ab b rev iations used: ACh, acetylcholine; BA, basilar artery; DMSO, dimethyl sulfoxide; EDRF, endothelium-derived relax ing factor; ET, endothelin; 5-HT, 5-hydroxytryptamine; NOLAG, �-nitro-L-arginine; PGF2a, prostaglandin F2a; UTP, uridine triphosphate. 845 10-5 M BQ-123. In segments precontracted with 10-6 M serotonin, ET-3, but not ET-I, induced relaxation at low concentrations (10-11_10-8 M), with maximum relax ation amounting to 17.8 ± 14.7% of precontract ion (mean ± SD; n = 16). The relaxant action of ET-3 was abolished in vessels incubated with NG-nitro-L-arginine (10-5 M), an inhibitor of nitric oxide synthase. These results indi cate that the ET-induced contraction of the isolated rat BA involves activation of the ETA receptor. The ET-3induced relaxation of precontracted rat BA is apparently mediated by release of nitric oxide from the endothelium.
amino acid polypeptide that was discovered by Yanagisawa et aI. (1988) . At least three ET peptides have been shown to exist-ET-l, ET-2, and ET-3which are encoded by separate genes (Inoue et al., 1989) .
In vascular preparations obtained from different peripheral organs, veins are more sensitive to ET-l than arteries (D'Orleans-Juste et aI., 1989) , whereas in the cerebral circulation ET-l is more potent in pial arteries compared with veins (Hardebo et aI., 1989; . A pro nounced and long-lasting contraction after applica tion of ETs was found in isolated big-and small caliber cerebral arteries obtained from different species (Saito et aI., 1989; Asano et aI., 1990; Ed wards and Trizna, 1990; Godfraind et aI. . , 1990; Kauser et aI., 1990; Garcia et aI., 1991; Encabo et aI., 1992; Adner et aI., 1993; Salom et aI., 1993) and also from humans (Hardebo et aI., 1989; Martin de Aguilera et aI., 1990; Papadopoulos et aI., 1990) . Using isolated perfused cerebral arteries, the con tractile action of ET-l was more marked after ex traluminal than intraluminal application (Ogura et aI., 1991) , and similar results were obtained in vivo (Mirna et aI., 1989) ; this finding may be due to the presence of the blood-brain barrier. When applied topically, ET-l induced a pronounced constriction of cerebral arteries (Armstead et aI., 1989; Faraci, 1989; Mirna et aI., 1989; Murray et aI., 1992) and a decrease in regional cerebral blood flow (Robinson et aI., 1990; Willette and Sauermelch, 1990; Macrae et aI., 1993; Sharkey et aI., 1993) .
Two subtypes of ET receptors have been charac terized using pharmacological techniques (Maggi et aI., 1989) . The ETA subtype is characterized by the agonist order of potency of ET-l = ET-2 > ET-3 whereas at the ET B receptor, the three ETs are equipotent (Haynes et aI., 1993) . Recently, specific antagonists of the ETA receptor, such as BQ-123 (Ihara et aI., 1992) and FR139317 (Adner et aI., 1993) , have become available; furthermore, com pounds exhibiting agonistic and antagonistic effects on the ET B receptor have also been described (Kar aki et aI., 1993) . The ETA receptor, which is found on smooth muscle cells, mediates cerebrovascular contraction (Adner et aI., 1993; Salom et aI., 1993) , while activation of the ET B receptor, located on endothelial cells, induces vascular smooth muscle relaxation by releasing prostacyclin and/or EDRF (DeNucci et aI., 1988; Fukuda et aI., 1990; Sud jarwo et aI., 1992) . However, experimental evi dence has accumulated that there may be atypical or additional ET receptor subtypes in vascular and nonvascular smooth muscle (Cardell et aI., 1992; Moreland et aI., 1992; Eglezos et aI., 1993) .
Due to its long-lasting action, ET has been im plied in the pathogenesis of cerebral vasospasm. In fact, an increase of the concentration of ETs in the cerebrospinal fluid of patients suffering from vaso spasm following subarachnoid hemorrhage has been described (Ehrenreich et aI., 1992; Suzuki et aI., 1992) . Further evidence for an involvement of ET has been obtained from experimental studies in dogs. In these studies, the spastic reaction of the canine basilar artery following experimental sub arachnoid hemorrhage was significantly attenuated by application of ETA receptor antagonists (Clozel and Watanabe, 1993; Nirei et aI., 1993) or of phos phoramidon, an inhibitor of the endothelin-con verting enzyme (Matsumura et aI., 1991) . There fore, studies on the cerebrovascular actions of ETs are also of clinical importance.
Since a full concentration-response curve for ETs was not available for large-diameter cerebral arteries of the rat, the present study was designed to investigate the effects of the three ET peptides on isolated rat basilar artery (BA) and to compare the effects of ET-l in rat and rabbit BA. The receptor J Cereb Blood Flow Metab, Vol. 14, No. 5, 1994 subtype underlying the contractile effects of ET-1 and ET-3 was characterized in rat BA using the specific ETA receptor antagonist, BQ-123 (Ihara et aI., 1992) . In addition, the relaxant potency of ET-l and ET-3 was investigated in rat BA pre contracted with serotonin [5-hydroxytryptamine (5-HT)] and further characterized using the specific inhibitor of nitric oxide synthase, N G -nitro-L-arginine (NOLAG), which has been shown to suppress the endothelium-dependent relaxation to acetylcholine in the rat isolated BA (Schilling et aI., 1990) .
MATERIALS AND METHODS

Drugs
ET-1, ET-2, and ET-3 were purchased from Peninsula (Heidelberg, Germany), uridine-5'-triphosphate (UTP) from Serva (Heidelberg, Germany), and 5-HT creatinine sulphate, acetylcholine chloride (ACh), NOLAG, and di methyl sulfoxide (DMSO) from Sigma (Deisenhofen, Ger many). BQ-123 [Cyclo(D-Asp-Pro-D-Val-Leu-D-Trp)) was a gift from Dr. Dagmar Pettig (BASF, Ludwigshafen, Germany). Stock solutions of ETs were dissolved and diluted in sterile bidistilled water. Stock solution of BQ-123 (10-2 M) was prepared in pure DMSO and dissolved in physiologic saline (0.9% NaCI), while the other com pounds were made up in 0.9% NaCI. All solutions were prepared fresh on the day of each experiment and were kept on ice throughout the experiment.
Animal preparation
Male Wistar rats (250--350 g) and New Zealand white rabbits (�1 kg) were exsanguinated from the carotid ar teries under anaesthesia (rats, ether; rabbits, pentobarb itone, 30 mg/kg i.v.). The brains were removed and placed in ice-cold modified Krebs-Hogestatt solutions of the following compositions (mM): in rats, NaCl, 119; KCl, 4.6; NaH2P0 4 , 1.2; CaCl2 • 2H20, 1.5; MgCl2 • 6H20, 1.2; NaHC03, 15; glucose, 10 (rats); and in rabbits, NaCl, 118; KCl, 4.75; KH2P0 4 , 1.19; CaCl2 • 2H20, 2.55; MgS0 4 • 7H20, 1.2; NaHC03, 25; glucose, 10 (Parsons et aI., 1991a) . Using a binocular mi croscope, the BA was meticulously dissected and trans ferred into 5-ml organ baths. The arteries were cut into ring segments (three to four segments in rats, six in rab bits) and mounted on two L-shaped 70-f.Lm-diameter metal prongs at room temperature, as described previ ously (Parsons et aI., 1991a) . Special care was taken to preserve the endothelium during preparation of the arter ies. One hanger was fixed to the bath while a second one was connected to a force transducer (Q 11, Hottinger Baldwin, Darmstadt, Germany) for measuring isometric force. The output was recorded on a multichannel pen recorder (Kipp & Zonen, Solingen, Germany). The Krebs solution was continuously bubbled with 90% O2 and 10% CO2 to maintain a pH of 7.25-7.3 (rat) or 7.3-7.4 (rabbit).
Experimental protocol
All vessels received a 90-min equilibration period with heating to 37°C and repeated washing every 10--15 min. The resting tension was adjusted to 2.5-3.5 mN in rat BA and 3-5 mN in rabbit BA. After the equilibration period, the segments were pre contracted with 5-HT (10-6 M, rat) or UTP (10-4 M, rabbit), and the functional integrity of the endothelium was tested on top of precontraction by cumulative application of ACh (10-8-10-4 M). The bath solution was then replaced and the vessels were allowed another 45-min resting period. Every preparation re ceived then a K + -rich (124 mM) Krebs solution (in which NaCI was replaced by KCl) as a standard contractile agent. Only segments that developed more than 2 mN force to K + -Krebs were used in the present study.
The contractile action of ET-l was investigated in rat and rabbit BA under resting tension by cumulative appli cation (10-1 2 _10-6 M). Rat BA was also exposed to ET-2 (10-1 4 _10-6 M) and ET-3 (10-1 2 _10-6 M) and to BQ-123
(10-1 0 _10-4 M), and concentration-response curves were constructed. To characterize the receptor subtype mediating the contraction induced by ET-I and ET-3, some vessels were incubated with BQ-123 (10-7-10-5 M) for 20 min before application of the ETs. The effects of low concentrations (10-1 2 _10-8 M) of ET-I and ET-3 were also tested in rat BA after precontraction with 5-HT (10-6 M) to reveal any relaxant component. Some seg ments were preincubated with NOLAG (10-5 M) for 20 min before precontraction with 5-HT to test whether the relaxation induced by ET-3 is due to a release of EDRF.
Only one concentration-response curve was performed in each segment.
Analysis of results
Results are expressed as mean ± SD. The contractile effects of ETs were calculated in percent of contraction induced by 124 mM K + -Krebs solution, and relaxant re sponses by ET-3 were expressed in percent of 5-HT induced precontraction. The slopes of the concentration- response curves were calculated from individual experi ments using the data points below and above the EC5 0 value, where EC 5 0 is the concentration producing 50% of the maximal response, Em ax . For both contractile and relaxant responses, the pD2 value ( -IOglO ECso) was cal culated for individual concentration-response curves. The shift of the averaged pD2 values in the presence of different concentrations of BQ-123 was calculated, and the pA2 value was computed by the method of van Rossum (1963) 
, where x is the ratio of mean EC5 0 values in the presence of the an tagonist and under control conditions, and [A] is the mo lar concentration of the antagonist. For statistical evalu ation of the results, one-way analysis of variance (ANOV A) was used, followed by Tukey's honestly sig nificant difference (HSD) mUltiple-range test; p < 0.05 was taken to indicate significance.
RESULTS
The contraction to K + -Krebs solution, which served as the reference contraction, was 5.4 ± 1.7 mN in rat BA (n = 73) and 6.2 ± 1.6 in rabbit BA (n = 29). Application of ET-I, ET-2, and ET-3 re sulted in concentration-related contracti . ons as shown in Figs. 1 and 2 . In the rat BA, the order of potency was ET-I = ET-2 > ET-3, but no signifi cant differences were found in the maximum con tractions and the slopes of the concentration response curves, although the curve for ET-3 ap peared to be somewhat steeper than those for ET-I and ET-2 (Table 1 ). The specific ETA receptor an tagonist BQ-123 was used to characterize the recep- Shown are threshold concentrations, pOz values, and maximum contractions (Emax) for endothelin (ET)-I, ET-2, and ET-3 in rat and rabbit isolated basilar artery. Threshold concentration is defined as the lowest concentration that induced a statistically significant contraction (p < 0.05) compared with solvent application. Emax is expressed as percentage of contraction to K + -Krebs solution; pOz and E m ax values are means ± SO with the number of observations indicated in parentheses; NO, not determined. a p < 0.05 vs. tor subtype activated by ET-l and ET-3 in the rat BA. When applied to vessel segments under resting tension, BQ-123 had no effect in low concentrations but exerted a small contraction at 10-4 M (Fig. 3) . This contractile action appears to reflect intrinsic activity of BQ-123, because in control experiments, DMSO (the solvent for BQ-123) did not induce any contraction even at the highest concentration ap plied (equivalent to that present in the bath with 10-4 M BQ-123). When ET-I was applied to seg ments pre incubated with different concentrations of BQ-123 (10-7-10-5 M), a rightward shift of the con centration-response curve to ET -1 was noted with out any decrease of the maximum contraction (Fig.  4) . The shift, which became larger with increasing concentrations of BQ-123, was calculated at the level of the EC 5 0 values (Table 2) . From these data, a pA2 value of 6.935 was calculated for BQ-123. The slope of the regression curve was 0.734, close to 1. When ET-3 was investigated in the presence of 10-5 M BQ-123, its contractile action was com pletely suppressed up to the highest concentration applied (10-6 M). In contrast to its inhibitory action on ET-induced contraction, BQ-123 (10-5 M)did not affect contraction evoked by application of 10 -5 M prostaglandin F2cx (PGF2cx) as shown in additional experiments; the results were 2.4 ± 1.3 mN in the absence (n = 10) and 2.8 ± 1.3 mN in the presence (n = 10) of BQ-123. As shown in Fig. 1, there was no indication what soever of a relaxant component induced by ET -l or ET-2. Furthermore, ET-l did not induce any relax ation in 5-HT-precontracted arteries. However, Shown are the effects of different concentrations of BQ-123 on pD2 values obtained for endothelin (ET)-l and ET-3 in rat isolated basilar artery; shift, the difference between ECso and control values. Values are given as means ± SD with the number of observations indicated in parentheses; ND, not determined.
there was a small (statistically insignificant) de crease of resting tension by low concentrations of ET-3 00-1 0 -10-8 M). Therefore, the effect of low concentrations of ET-3 was investigated in 5-HT 00-6 M)-precontracted arteries. In these experi ments, only segments with a functionally intact en dothelium, as indicated by a concentration-related relaxation to ACh (Emax, 49.3 ± 15.1%; n = 16), were used. As shown in Fig. 5 , there was a concen tration-related relaxation of these pre contracted ar teries to ET-3 in the range of 10-1 2 _10-8 M. With higher concentrations of ET-3, the 5-HT-induced contraction was further enhanced. In some ex periments, the segments were preincubated with NOLAG 00-5 M) for 20 min to block the release of EDRF from the endothelium. NOLAG induced an increase of resting tension of 1.6 ± 2.0 mN (n = 8) while the 5-HT-induced contraction (3.6 ± 1.6 mN; n = 16) was not enhanced in the presence of NOLAG (4.2 ± 1.7 mN; n = 8) (p > 0.05). Fur thermore, NOLAG abolished the relaxant action of ET-3, as shown in Fig. 5 .
DISCUSSION
In the present study, concentration-related con traction of the rat isolated BA occurred after cumu lative application of ET-l, ET-2, or ET-3 and of rabbit BA after application of ET -1. The contrac tion had a rather fast onset and was very sustained, especially in response to ET-l and ET-2. In accor dance with studies from other groups (Alafaci et aI., 1990; Encabo et aI., 1992) , no contraction could be elicited by repeated application of ET -1, indicating tachyphylaxis. Therefore, only one concentration response curve was performed in each experiment.
The order of potency found in rat BA was ET-l = ET-2 > ET-3, which indicates activation of an ETA receptor subtype underlying the contractile ac tion of ETs (Haynes et aI., 1993) . This is in accor dance with the results obtained in middle cerebral and basilar arteries of the dog (Saito et aI., 1991) , goat (Salom et aI., 1993) , and guinea pig (Adner et aI., 1993) and in intraparenchymal arteries of the rat (Edwards and Trizna, 1990 ). In addition, using cul-tured smooth muscle cells of the canine basilar ar tery, the same order of potency was found for ETs in inducing an increase in intracellular Ca 2 + con centration (Takenaka et aI., 1993) . There are, how ever quantitative differences between the pD2 val ues obtained in the present study and those pub lished in the literature for rat cerebral arteries. In isolated perfused small extra-or intraparenchymal arteries, pD2 values of 9.70 (Godfraind et aI., 1990) and 9.15 (Edwards and Trizna, 1990 ) have been found, indicating a higher sensitivity to ET-l than shown by the BA under our experimental condi tions. A pD2 value of 9.3 has been reported for rat BA ring segments by Alafaci et aI., (990) , which differs from our results. However, this pD2 value of 9.3 is at best a rough estimate, since the authors did not construct the full concentration-response curve. Furthermore, our results are in good agreement with those obtained by Murray et aI. (992) for rat BA in vivo. From their data, a pD2 value of approx imately 8.1 (8.085 in the present study) can be in ferred.
The conclusion that the ET-induced contraction of cerebral arteries is mediated by the ETA receptor is further strengthened by the results obtained with BQ-123, a specific ETA receptor antagonist (lhara et aI. , 1992) . Specificity of BQ-123 in rat isolated BA is reflected by the fact that it did not affect contraction induced by PGF2a which is in good agreement with results obtained in goat isolated middle cerebral artery precontracted with 5-HT (Salom et aI. , 1993) . In the low-concentration range (:;;; 10-5 M), BQ-123 was devoid of any vasomotor effects, while at 10-4 M it induced a small contrac tion (see Fig. 3 ), eventually reflecting intrinsic ac tivity. In the lower concentration range, where it lacks any intrinsic activity, BQ-123 elicited a con centration-related rightward shift of the ET -1induced contraction without depressing the maxi mum effect. The slope of the regression curve was 0.734, close to 1, indicating competitive inhibition of ET -I-induced contraction of rat isolated BA. The pA2 value of 6. 935 calculated here for BQ-123 is comparable to that found for FR139317, another pu tative ETA receptor antagonist, in guinea pig iso lated middle cerebral artery (Adner et aI. , 1993) . Compared with the present results, a somewhat big ger pA2 value (7.43) and also a higher slope of the regression curve for BQ-123 (1.31) was described in goat isolated middle cerebral artery (Salom et aI. , 1993) , but the pD2 value obtained for ET-1 was also markedly higher (9.54) than in the present study. The reason for the quantitative discrepancies in goat and rat isolated cerebral arteries is not clear, but the differences may be due to species andlor vessel (middle cerebral vs. basilar artery) varia tions.
In the presence of 10-5 M BQ-123, the ET-3induced contraction was completely abolished, sug gesting activation of the smooth muscle ETA recep tor by ET-3. However, an indirect action causing release of ET-1 from endothelial cells by ET-3 (Yokokawa et aI. , 1991) must also be considered, since experiments in the present study were per formed in vessel segments with functionally intact endothelium. Therefore, further experiments are planned to test whether the contractile activity of ET-3 is different in vessel segments devoid of a functional endothelium.
The present article is the first to describe a relax ant activity of an ET peptide, ET-3, in isolated ce rebral arteries. There was no indication for a relax ant action of ET-1 and ET-2 under resting tension or after precontraction with 5-HT. In contrast, low J Cereb Blood Flow Metab, Vol. 14, No. 5, 1994 concentrations of ET -3 induced some decrease of resting tension and relaxation of 5-HT-precon tracted vessels. Whether such relaxant action oc curs in cerebral arteries in vivo has not yet been studied. Dilatation during topical application of ET-1 has, however, been observed in pial arteries of rats (Faraci, 1989) and piglets (Armstead et aI., 1989) but not in rat BA in vivo (Faraci, 1989; Mur ray et aI. , 1992) .
The receptor underlying ET-3-induced relaxation has not been characterized in the present study. In peripheral arteries, ET -3 induced relaxation by ac tivating ET B receptors located on the endothelium. The relaxation was accompanied by a rise of the intraendothelial Ca 2 + concentration (Emori et aI. , 1991; Yokokawa et aI. , 1991; Sudjarwo et aI. , 1992) and mediated by release of relaxant prostanoids and EDRF (Yokokawa et aI., 1991; Sudjarwo et aI. , 1992) . To study the relaxant action of ET-3, seg ments with a functionally intact endothelium were used, as indicated by a marked although incomplete (i. e. , <100% of precontraction) relaxation to ACh, which is in good agreement with previous results published by ourselves (Schilling et aI. , 1990) and by others (Lai et aI., 1989) . This incomplete relax ation is a characteristic of isolated rat BA and does not appear to be due to technical or methodical causes such as enhanced production of superoxide radicals due to the high partial pressure of oxygen in the organ bath. Although free superoxide radicals can quench the effect of EDRF by destroying nitric oxide, we found ACh-induced relaxation only mar ginally enhanced (by 14%) in the presence of high concentrations of superoxide dismutase (1,200 V Iml with 1,600 Vlml catalase, unpublished observa tions). In addition, we have observed almost com plete relaxation by ACh in isolated rabbit middle cerebral artery (Parsons et aI. , 1991b) . Therefore, our experimental conditions are definitely appropri ate for studying endothelium-dependent relaxation. The results of the present study indicate that the ET -3-induced relaxation of cerebral arteries is most probably also endothelium-dependent and mediated by release of EDRF, since it was completely blocked by preincubation with an inhibitor of nitric oxide synthase, NOLAG. This and other inhibitors have been demonstrated to suppress the endothe lium-dependent relaxation by ACh in the rat BA in vitro (Schilling et aI. , 1990) and in vivo (Faraci, 1990) .
Whether the ET-3-induced relaxation of cerebral arteries is also due to activation of ET B receptors will be studied by using specific agonists and antag onists such as sarafotoxin 6c or IRL 1620 and IRL 1038, respectively (Eglezos et aI. , 1993; Karaki et al., 1993) . If ET B receptors are activated, they should also be activated by ET -1 in a similar con centration range as found for ET-3, because the ET B receptor is nonselective. Therefore, with low concentrations of ET -1, the vasomotor effect should be composed of relaxant and contractile components competing with each other. One may thus anticipate some potentiation of the ET -1induced contraction in the presence of NOLAG. However, in the rat BA this was not the case (re sults not shown). This observation may suggest the presence of an atypical ET receptor in cerebral ar teries, possibly with preferential affinity to ET-3. Furthermore, it may indicate that even a small in crease in the concentration of ET -1 in the cerebro spinal fluid following subarachnoid hemorrhage will result in constriction of large-diameter cerebral ar teries and may thus contribute substantially to the development of vasospasm. In contrast, ET-3 in low concentrations may tend to dilate these vessels, and ET-3 may enhance constriction only in high concentrations.
